source
- Aardvark to unblind rare disease trial after FDA places full clinical hold; Alumis issues verdict on Acelyrin assetAardvark's rare disease candidate is under a full clinical hold by the FDA, which has paused all dosing and data collection. The company says it intends to unblind the trial data despite the hold,…
- Older adults warn that changing pill colors and shapes cause dangerous confusionBarbara Wolf, a 73‑year‑old from Birmingham, Alabama, takes six medications each day and relies on the color, shape and size of each pill to keep her regimen straight. She recently received a refi…